Two offers, same title, same base pay: one from a twelve-person device startup, one from an established manufacturer with a regulatory department twenty deep. Neither is the correct answer by default. They teach different things at different speeds, and knowing which tradeoffs you’re actually making beats guessing from the size of the logo.
What you actually get more of at a startup
Broad, fast exposure is the real advantage. With no one ahead of you who has written the regulatory strategy before, you often write the first version yourself — the first submission plan, the first labeling review process, the first attempt at a design history file. You get direct access to whoever is making the product decisions, because there usually isn’t a layer of management between you and them. The tradeoff is exactly the flip side: fewer people are positioned to catch it if you get something wrong, and a small team means you may not find out you learned a step incorrectly until it surfaces somewhere expensive, like an FDA response or an audit finding.
What you actually get more of at an established company
Precedent and people. A device manufacturer that has been through hundreds of 510(k)s or years of drug submissions has procedures, templates, and colleagues who have already made the mistakes you’re about to make — and can tell you before you make them. Training budgets and RAC exam support are more likely to be a defined line item than a favor someone does for you. The narrower part is real too: your first year might be one product line, one submission type, one small piece of a much larger regulatory operation, and it can take longer to see how the pieces connect. Both environments answer to the same underlying obligations — the Quality Management System Regulation in 21 CFR Part 820 applies the same way to a startup's first product as to an established manufacturer's twentieth — what differs is how much of that system is already built and staffed when you arrive.
Where people get stuck
Assuming “more responsibility, faster” is automatically good
Speed and scope are only an advantage if you have some way to check your own work. Ask directly who reviews what you produce, and how often, before you take the scope as a selling point.
Assuming a recognizable employer guarantees mentorship
A large regulatory department can still leave a junior hire under-supervised inside a big org chart. Mentorship is a specific commitment from a specific person, not a property of company size — ask who it would be.
Choosing on title or prestige instead of the actual work
Ask for a description of a typical week, not just the job posting. Two roles with the same title can be almost unrelated in what you'd spend your days doing.
The company-size question is really a handful of smaller, answerable questions: who reviews your work before it goes out, how the team has grown or shrunk over the last two years, and what happens to your role if funding or ownership changes. Ask those directly in the interview rather than relying on headcount as a proxy — it’s a better predictor of what your first 90 days will actually look like than the size of the company on the offer letter, and it matters again later, whether you’re thinking about building depth in one product area or working out where you sit on the career ladder.
Sources & further reading
- 21 CFR Part 820 — Quality Management System Regulation ecfr.gov
- Regulatory Academy — How to Get Into Regulatory Affairs, the Honest Map regulatoryacademy.com
- Regulatory Academy — Your First 90 Days in Regulatory Affairs regulatoryacademy.com
- Regulatory Academy — The Regulatory Affairs Career Ladder, Explained regulatoryacademy.com
This essay is provided for general educational purposes and reflects the regulatory landscape as of its publication date. It is not legal, regulatory, or career advice.